Prevention of Recurrent Venous Thromboembolism (PREVENT)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00000614
First received: October 27, 1999
Last updated: March 15, 2016
Last verified: September 2005
  Purpose
A multicenter randomized, double blind placebo controlled trial to determine the efficacy of long-term, low dose warfarin in the secondary prevention of venous thromboembolism.

Condition Intervention Phase
Cardiovascular Diseases
Heart Diseases
Peripheral Vascular Diseases
Thromboembolism
Vascular Diseases
Venous Thromboembolism
Drug: warfarin
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Masking: Double-Blind
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1998
Study Completion Date: August 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   30 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
Patients with venous thromboembolism, including patients with factor V Leiden. Patients had completed prescribed anticoagulation therapy within the last two years before the trial and were not currently on anticoagulation therapy.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000614

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Investigator: Robert Glynn Brigham and Women's Hospital
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00000614     History of Changes
Other Study ID Numbers: 117  R01HL057951 
Study First Received: October 27, 1999
Last Updated: March 15, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Peripheral Arterial Disease
Peripheral Vascular Diseases
Thromboembolism
Vascular Diseases
Venous Thromboembolism
Arterial Occlusive Diseases
Arteriosclerosis
Atherosclerosis
Embolism and Thrombosis

ClinicalTrials.gov processed this record on May 23, 2016